Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Abdominal Aortic Aneurysm Growth (COIN)
NCT05361772Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
Randomised, double-blind trial of colchicine in abdominal aortic aneurysm (AAA), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Change in maximum diameter of abdominal aortic aneurysm at 24 months. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT05361772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361772.